The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial
- Resource Type
- Article
- Source
- In
The Lancet Gastroenterology & Hepatology April 2021 6(4):282-291 - Subject
Primary Research Articles - Language
- ISSN
- 2468-1253